Sort   by:  
 Page size 
Connexin43 (Cx43) is the predominant connexin in working myocardium. Its expression decreases in various cardiovascular diseases, and accompanied by ventricular arrhythmias (VAs). However, molecular mechanisms underlying increased arrhythmogenesis remained unclear. Here we established iPSC-derived c...
2025-11-11 | MTBLS13302 | MetaboLights
In a rabbit heart failure model, resveratrol treatment restored cardiac function, normalized calcium handling, and reduced ventricular arrhythmia by reversing ion channel downregulation, fibrosis, apoptosis, and inflammation. These findings highlight resveratrol’s cardioprotective potential as a the...
ORGANISM(S): Oryctolagus cuniculus (Rabbit) 
2026-01-12 | PXD069110 | Pride
Cardiac Arrhythmia Suppression Trial (CAST-BioLINCC)
Cardiac Arrhythmia Suppression Trial (CAST-BioLINCC)
Acute myocardial infarction (AMI) is one of the leading causes of death. It is particularly important to predict malignant ventricular arrhythmia (MVA) timely and accurately in patients with AMI. This study aimed to explore biomarkers and to reveal possible mechanisms of MVA in AMI for clinical diag...
ORGANISM(S): Homo sapiens (Human) 
2024-01-26 | PXD041535 | Pride
NHLBI TOPMed: The Cleveland Clinic Atrial Fibrillation Study of the CV/Arrhythmia Biobank
Sort   by:  
 Page size